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Streptococcus pneumoniae (Sp) is a commensal bacterium that normally resides on the
upper airway epithelium without causing infection. However, factors such as co-infection
with influenza virus can impair the complex Sp-host interactions and the subsequent
development of many life-threatening infectious and inflammatory diseases, including
pneumonia, meningitis or even sepsis. With the increased threat of Sp infection due
to the emergence of new antibiotic resistant Sp strains, there is an urgent need for
better treatment strategies that effectively prevent progression of disease triggered by
Sp infection, minimizing the use of antibiotics. The complexity of the host-pathogen
interactions has left the full understanding of underlying mechanisms of Sp-triggered
pathogenesis as a challenge, despite its critical importance in the identification of effective
treatments. To achieve a systems-level and quantitative understanding of the complex
and dynamically-changing host-Sp interactions, here we developed a mechanistic
mathematical model describing dynamic interplays between Sp, immune cells, and
epithelial tissues, where the host-pathogen interactions initiate. The model serves as a
mathematical framework that coherently explains various in vitro and in vitro studies,
to which the model parameters were fitted. Our model simulations reproduced the
robust homeostatic Sp-host interaction, as well as three qualitatively different pathogenic
behaviors: immunological scarring, invasive infection and their combination. Parameter
sensitivity and bifurcation analyses of the model identified the processes that are
responsible for qualitative transitions from healthy to such pathological behaviors. Our
model also predicted that the onset of invasive infection occurs within less than 2 days
from transient Sp challenges. This prediction provides arguments in favor of the use of
vaccinations, since adaptive immune responses cannot be developed de novo in such a
short time. We further designed optimal treatment strategies, with minimal strengths and
minimal durations of antibiotics, for each of the three pathogenic behaviors distinguished
by our model. The proposed mathematical framework will help to design better disease
management strategies and new diagnostic markers that can be used to inform the most
appropriate patient-specific treatment options.
Keywords: Streptococcus pneumoniae, upper airway epithelium, data integration, hybrid systems, commensal
bacteria, systems biology, antibiotics resistance
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1. INTRODUCTION
Streptococcus pneumoniae (Sp) is a commensal bacterium that is
part of the upper airway microbiota. While it normally resides
on the upper airway epithelium without causing serious infection
or tissue damaging inflammation (World Health Organization,
2012), factors such as co-infection with the influenza virus
often result in the development of life-threatening infectious
and inflammatory diseases, including pneumonia, meningitis or
even sepsis (World Health Organization, 2012; McCullers, 2014),
since these factors can cause a weakened immune response to
Sp or tissue damage that may disrupt the normal interactions
between Sp and host. The threat of Sp infection has been
increasing despite interventions by widely available antibiotics,
due to the increasing presence of multiple antibiotic-resistant
Sp strains (Nuorti et al., 1998; McCullers et al., 2000). Reduced
susceptibility to penicillin was detected in all WHO regions
(World Health Organization, 2014) and the pneumococcus
remains a major cause of morbidity and mortality, not solely
from the lower lung infection Siegel and Weiser (2015). There
is an urgent need to devise better intervention strategies that can
effectively halt the onset or persistence of Sp-mediated pathology
at its early stages using a minimal amount of antibiotics for
a short duration, in order to avoid the emergence of further
antibiotic-resistant Sp strains (Schrag et al., 2001; Prina et al.,
2015b).
Identification and design of effective intervention strategies
require systems-level and quantitative understanding of
the complex and dynamically-changing host-pathogen
interactions that can lead to either healthy Sp colonization
or pathological conditions, such as infection or inflammation.
This paper proposes a mathematical model of the host-pathogen
interactions between Sp and the upper airway epithelium, the
initial site of interaction between Sp and the host which is
the first step in all disease tiggered by this bacterium (Siegel
and Weiser, 2015). We analyse the model to systematically
and quantitatively investigate the mechanisms by which the
homeostatic interactions are disrupted, for example by a
weakened barrier function (McCullers, 2014) or immune
suppression (Didierlaurent et al., 2008), and cause the onset of
infectious processes.
Previously proposed mathematical models (Smith et al., 2011;
Shrestha et al., 2013; Smith et al., 2013; Mochan et al., 2014)
considered Sp infections in the lung which is a normally sterile
site of the airway epithelium. In this paper, we develop a
mechanistic model of homeostatic interactions between the
host’s upper airway and Sp as a commensal bacterium, based
on a variety of experimental data from in vivo and in vitro
studies. Given that the tissue-damaging effects of neutrophil
transmigration are responsible for part of the pathology of
infection (Chin and Parkos, 2007; Zemans et al., 2009), we
specifically model how impaired host-pathogen interactions
lead to loss of epithelial homeostasis and serious infection.
Our mechanistic model describes dynamic interplays between
Sp, immune cells, and epithelial tissues by a hybrid system
of ordinary differential equations (ODEs), and elucidates the
mechanisms by which commensal bacteria cause infection.
Our model demonstrates a robust behavior of healthy
clearance of asymptomatic pneumococcal colonization
without overt disease. Perturbation of the model parameters,
corresponding to virtual patient cohorts, demonstrates
three clinically observed pathological behaviors (disease
phenotypes) triggered by disrupted Sp-host interactions. Using
this mathematical model of pneumococcal colonization, we
further suggest optimal treatment regimens that minimize use of
antibiotics to intervene the pathogenic processes for each patient
cohort. As colonization is a prerequisite for all pneumococcal
disease (Siegel and Weiser, 2015), studying and the modeling of
colonization by Sp to understand its interaction with the host
could be important for not only looking at invasive infections but
also other types of interaction/infection of the pneumococcus
and host.
2. RESULTS
2.1. Mathematical Model of Sp
Colonization in the Upper Airway
Epithelium
Our proposed mathematical model of Sp colonization
(Figures 1A,B) is a system-level representation of the prominent
interactions between Sp, the airway epithelium, and immune
cells (a–j) in Figures 1A,B, that were identified based on the
empirical evidence from numerous experimental in vivo and
in vitro studies as detailed below.
Under homeostatic conditions, a population of commensal
bacteria, Sp, resides in the lumen on the apical side of the airway
epithelium, where they are contained by a competent epithelial
barrier integrity (Beisswenger et al., 2007) (Figures 1Aa,Ba)
and immune responses mediated by neutrophils and
macrophages (Dick et al., 2008; Standish and Weiser, 2009)
(Figures 1Ab,Bb). Through disrupted barrier, apically located
Sp can translocate to reach the blood vessel (Beisswenger et al.,
2007) (Figures 1Ac,Bc), where they are either killed by resident
immune cells that circulate in the blood (Li et al., 2002; Li, 2004),
or grow uncontrollably and result in invasive infection if the
immune cells cannot contain the translocated Sp (Silverstein and
Rabadan, 2012). The amount of the translocated Sp in the blood
vessel is therefore a determinant of whether disrupted Sp-host
interactions cause serious infection such as sepsis.
Translocation of Sp occurs through the airway epithelial
barrier, whose integrity is regulated by the apically located
bacteria load. The bacteria bind to Pattern-Recognition immune
receptors, specifically Toll-like receptors (TLR2s) that are
preferentially expressed on the apical side of the airway
epithelial cells (Melkamu et al., 2009), and activate the
TLR signaling cascade (Figures 1Ad,Bd). The activation of
the TLR cascade in epithelial cells decrease the barrier
integrity of the airway epithelium (Figures 1Ae,Be) by TLR-
mediated activation of proteases that damage the epithelial
cells (Oggioni et al., 2004; Schmeck et al., 2004; Attali
et al., 2008; Tieu et al., 2009) and by reduction of the
barrier recovery rate due to the increased expression of the
transcriptional repressor SNAIL1, which inhibits the expression
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FIGURE 1 | A mechanistic model of Sp. colonization. (A) A schematic diagram of the processes included in the model. (B) The dynamic interplay between
environmental stressors, barrier function and immune responses regulates infiltration of Sp to the blood vessel, which can result in infection. (C) R-switch for reversible
activation of TLRs. (D) Sv-switch for the threshold behavior (invasive infection or containment) of the infiltrated Sp in the blood vessel.
of claudin, a component of the tight junctions (Clarke et al.,
2011).
Active TLR signaling also induces recruitment of neutrophils
from the neutrophil pool in the blood vessel, via the release of
IL-17 (Zhang et al., 2009) that activates neutrophil-attracting
interleukins IL-8 (Lindén, 2001) (Figures 1Af,Bf). The recruited
neutrophils trigger transmigration of macrophages to the
site of infection (Zhang et al., 2009), further potentiating
the immune responses to the apically located pathogens
(Figures 1Ag,Bg), whereas macrophages on the lumen restrict
neutrophil transmigration (Zhang et al., 2009) by releasing
neutrophil-repellent anti-inflammatory cytokines (Knapp et al.,
2003) (Figures 1Ah,Bh). Transmigrating neutrophils release
barrier degrading proteases (Chin et al., 2008) to reduce the
barrier integrity (Nash et al., 1987; Nusrat et al., 1997; Zemans
et al., 2009) (Figures 1Ai,Bi). The reduced barrier integrity
in turn allows more transmigration of both neutrophils and
macrophages from the blood vessel to the site of infection (Nash
et al., 1987) (Figures 1Aj,Bj).
The model elucidates the main control structure of the system
that maintains homeostatic interactions between commensal
bacteria, Sp, and the host, via a dynamic interplay between
environmental stressors, epithelial barrier integrity and immune
responses (Figure 1B). At the apical side of the airway
epithelium, Sp load is regulated via activation of TLRs, which
induce immune responses that decrease the bacterial load but
also reduce the epithelial barrier integrity. While the reduced
barrier integrity enables transmigration of immune cells from
the blood vessel for effective killing of Sp at the apical
side of the epithelium barrier, it also allows transmigration
of Sp from the apical side of the epithelium to the blood
vessel, potentially causing systemic infection (sepsis). The
dynamic interplay between the immune responses and the
epithelial barrier integrity are further modulated by their mutual
inhibition.
Our model further assumes two switches, an R-switch for TLR
activation and an Sv-switch for the growth of the transmigrated
bacteria in the blood vessel, based on the experimental evidence
described below. The R-switch for Sp-mediated activation of
TLRs reflects the observations that low concentrations of Sp do
not cause activation of TLR signaling, while high concentrations
lead to a sharp increase in TLR activity with hysteresis (He
et al., 2009; Shalek et al., 2013; Sung et al., 2014). We model
the R-switch by a perfect switch, which is a phenomenological
representation of the bistable switch (Sung et al., 2014), and is
described by the off- and on-states (R = Roff and Ron) with the
activation (S+) and inactivation (S−) thresholds for the critical
concentrations of apically located Sp that abruptly and sharply
turn on-or-off TLR activity (Figure 1C and Equation 2). The
Sv-switch reflects the observations that transmigrated bacteria
in the blood vessel (Sv) either overgrow (Benton et al., 1997)
or are contained by resident immune cells depending on the
bacterial concentration (Supplementary Figure 3B). We model
the Sv-switch with a switching threshold of S
∗
v , above which
the infiltrated bacteria in the blood vessel grow exponentially
(Figure 1D).
The resulting model is described by a hybrid system
of five ODEs (Equation 1). The nominal values of the 24
model parameters (Table 1) were derived by fitting the model
outcome to datasets from 11 independent studies, namely
three in vivo studies (Benton et al., 1997; Zhang et al.,
2009 and our own experiment) and eight in vitro studies
(Nash et al., 1987; Coyne et al., 2002; Lagrou et al., 2003;
Attali et al., 2008; Chin et al., 2008; Komori et al., 2011;
Hathaway et al., 2012; Kwok et al., 2012), as detailed in
the Supplementary Material. Our model therefore provides a
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TABLE 1 | Nominal parameters of the model.
Parameter Description Value References
Nv Size of the neutrophil pool 10
8 Tanaka et al., 2015
δN N degradation rate 6.1× 10
−2/h Tanaka et al., 2015
κB Barrier recovery rate 4.6× 10
−2/h Coyne et al., 2002
κS Bacteria growth rate 4.8× 10
−1/h Hathaway et al., 2012
B˜ Nominal barrier integrity 1
S+ Activation threshold for R-switch 107 CFU/ml Komori et al., 2011; Kwok et al., 2012
S− Deactivation threshold for R-switch 103 CFU/ml Komori et al., 2011; Kwok et al., 2012
θS Rate of bacterial transmigration through barrier 1.1× 10
−4/h Lagrou et al., 2003; Attali et al., 2008; Zhang et al., 2009
ǫSB Inhibition rate of Sa transmigration by B 3.1 Lagrou et al., 2003; Attali et al., 2008; Zhang et al., 2009
ǫBS Inhibition rate of B recovery by Sa 2.6× 10 ml/CFU Lagrou et al., 2003; Attali et al., 2008
φSB Degradation rate of B by Sa 1.4× 10
−1ml/CFU×h Lagrou et al., 2003; Attali et al., 2008
ǫNB Inhibition Rate of N recruitment by B 3.6× 10 Nash et al., 1987; Chin et al., 2008
ǫMB Inhibition rate of M recruitment by B = ǫNB Nash et al., 1987; Chin et al., 2008
φNB Degradation rate of B by N 4.0× 10
−8 ml/cells×h Nash et al., 1987; Chin et al., 2008
µS Saturation limit for Sa 3.7× 10
4 CFU/ml Zhang et al., 2009
φNS Rate of Sa killing by N 6.1× 10
−4 ml/cells× h Zhang et al., 2009
φMS Rate of Sa killing by M 6.3× 10
−3 ml/cells× h Zhang et al., 2009
K Half-killing constant of Sv 1.3× 10
4 CFU/ml Benton et al., 1997 and Figure S3
δS Rate of Sv killing by circulating immune cells 6.9× 10
3 cells/ml×h Benton et al., 1997 and Figure S3
α Rate of N recruitment by Sa 0.465× 150x10
(−8) ml/CFU×h Zhang et al., 2009
ǫNM Inhibition rate of N recruitment by M 1.6× 10
−1 ml/cells Zhang et al., 2009
β Rate of M recruitment by N 2.6× 10−2 ml/cells× h Zhang et al., 2009
Mv Number of macrophage pool 3.0× 10−1 cells/ml Zhang et al., 2009
δM M degradation rate 6.4× 10
−5/h Zhang et al., 2009
coherent mathematical framework to explain both in vivo and
in vitro data.
2.2. Healthy Clearance of Asymptomatic
Sp Colonization is Robustly Observed
One of the dataset used for the parameter estimation was
obtained from in vivo studies in Zhang et al. (2009),
where the mice were challenged with 107 CFU of Sp and
recovered their healthy state, which is characterized by nonzero
apical commensal bacterial load that does not trigger host
responses. Our model was fitted to reproduce the experimental
measurement in Zhang et al. (2009) for the apical bacterial load
(Sa) and the concentrations of neutrophils (N) and macrophages
(M) (Figure 2A). Both the experimental data and our model
simulation demonstrate that the transient Sp challenge (increase
of Sa) triggers a transient increase in N and a subsequent
increase in M. These immune responses can bring Sa down
to a homeostatic level, when the saturation limit for Sa is not
high enough, which enabled the recovery of the mice from the
bacterial challenge within 7 days without demonstrating invasive
infection.
The simulation of our model with the data-calibrated nominal
parameters further predicts the dynamics of three variables that
were not measured in this experiment, TLR activity (R), barrier
integrity (B) and infiltrated Sp in the blood vessel (Sv), thereby
explaining the underlying mechanism of the healthy recovery
from a bacterial challenge. Upon a Sp challenge, the apically
located bacterial load becomes high enough (Sa(0) > S
+) to
activate TLRs (R = Ron), which trigger recruitment of immune
cells to the site of infection. These immune responses bring
the initially high Sa down to below S
−, where the R-switch
turns off (R = Roff) and stays off as Sa remains below S
+, as
suggested by the focal point analysis (seeMethods). The epithelial
barrier integrity (B) continuously decreases while the R-switch
is on (R = Ron), allowing bacteria to invade the blood vessel,
as demonstrated by a rise in Sv. However, a healthy clearance
of Sv is achieved without causing sepsis, since the peak of Sv
remains below the threshold, S∗v , of the Sv-switch. Note that both
the experiments and our model simulation demonstrate that M
stays high while B is kept high after N goes to zero, suggesting
the importance of M as an immune mediator that does not
compromise the barrier integrity.
The healthy recovery behavior described above is
characterized in our model by convergence to the off-state
of TLR activity (R = Roff) accompanied by the containment
of Sv (Sv < S
∗
v), and is robustly observed under perturbations
to the parameter values. Among 10,000 simulations conducted
by randomly sampling parameter values from an uniform
distribution over two orders of magnitude around the nominal
values, 83% of the simulations demonstrated a healthy recovery
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FIGURE 2 | Healthy recovery from a transient Sp challenge. Blue circles and solid lines represent the in vivo experimental data from Zhang et al. (2009) and the
model prediction, respectively.
from a transient Sp challenge (Figures 3A,B). In 98% of the
healthy recovery cases computationally observed, Sv reached its
peak while R = Ron (Figure 3E), suggesting that the appropriate
host responses via TLR activation are responsible for containing
Sv. The appropriate level of the barrier damage by active TLRs
enables effective recruitment of immune cells that can reduce Sa,
but prevents excessive transmigration of Sa to Sv, keeping the
Sv lower than the threshold, S
∗
v . The robust appearance of the
healthy recovery in our model simulations confirms that that our
model can coherently explain the mechanism behind the healthy
recovery of the host from pneumococcal colonization, which can
be effectively cleared by the natural host responses without any
treatments.
2.3. Four Phenotypes Classified by the
Double Switch
The remaining 17% of the simulations with parameters perturbed
from their nominal values demonstrated systems dynamics
that correspond to serious infection or inflammation. They
are classified into three disease phenotypes, depending on the
states of the Sv- and R-switches (Figure 3A). The state of the
Sv-switch determines whether sepsis occurs due to invasive
infection of Sv(> S
∗
v), and that of the R-switch determines
whether immunological scarring occurs due to persistent host
responses caused by R = Ron. Immunological scarring refers
to the cumulative and long-term effects of immune response
to pathogens, including tissue remodeling and altered immune
responses to new pathogenic challenges, that persist after
the pathogenic organism has been cleared (Fonseca et al.,
2015). In our simulations, 13% demonstrated sepsis without
immunological scarring (Sv > S
∗
v and R = Roff) and the other
two disease phenotypes, immunological scarring (R = Ron) with
and without sepsis, were observed 2% each (Figure 3A).
Immunological scarring is characterized by a persistent on-
state of the R-switch due to Sa staying above S
− (Figure 3C). The
R-switch triggers persistent host responses leading to sustained
immune responses which are not strong enough to decrease Sa
below S− but cause persistent barrier damage. Note that the peak
of N is much lower in the immunological scarring phenotype
than that in the healthy recovery and sepsis phenotypes with
R = Roff (Figures 3B,D), resulting in weak immune responses
that are not sufficient to decrease Sa. As a result, the host becomes
vulnerable to a second bacterial attack due to the damaged barrier
and the sub-threshold concentration of Sv (< S
∗
v), which stay as
silent remainders of the first pathogenic challenge.
Sepsis is characterized by outgrowth of Sv once it surpasses
the threshold S∗v (Figure 3C). In 99.7% of the sepsis phenotypes
simulated by our model, the onset of sepsis occurs (when Sv = S
∗
v
is achieved) while R is on (Figure 3G), suggesting that whether
sepsis occurs or not is determined by the dynamics of Sv while
R is on. It is similar with the healthy recovery case, where
Sv reaches its peak below the threshold S
∗
v , while R is on.
Moreover, the duration of R = Ron is much longer for the
sepsis phenotype compared to the healthy recovery phenotype
(Figure 3H), suggesting that persistent host response may allow
excessive transmigration of Sp into the blood vessel above S∗v .
When both the Sv- and R-switches are on, sepsis is
accompanied by immunological scarring (Figure 3E), where the
barrier is severely damaged and Sv continues increasing above S
∗
v ,
while Sa remains above S
−.
The four phenotypes, including a healthy phenotype and
three disease phenotypes, correspond to different patient cohorts
observed in the clinic. Healthy recovery from colonization is the
most common outcome of host-pneumococcal interactions
(Austrian, 1986) and corresponds to patients who can
clear their symptoms from transient infection without any
antibiotics treatment. Sepsis corresponds to patients who would
develop systemic infection as a consequence of dysregulated
transepithelial crossing of bacteria if no treatment is applied
(Clarke et al., 2011; Siegel and Weiser, 2015). Immunological
scarring corresponds to tissue-damaging inflammation that
prevails even after clearance of the pathogens (Periselneris et al.,
2015). The long-term deleterious consequences of such sterile
inflammation and the associated tissue restructuring/damage
are considered to underlie many diseases, including pulmonary
fibrosis associated to previous Sp infections (Knippenberg et al.,
2015), chronic obstructive pulmonary disease (Garcha et al.,
2012) and cancer (Elinav et al., 2013; Pradere et al., 2014).
A sustained activation TLR is recognized to be an important
molecular player responsible for this tissue damage (Pradere
et al., 2014), as in our model. Sepsis with immunological scarring
corresponds to patient cohorts who would develop a severe
infection with long-term deleterious effects in absence of
treatment (Leibovici, 2013).
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FIGURE 3 | Four phenotypes resulting from alterations in the Sp-host interactions. (A) Four (a healthy and three pathological) phenotypes determined by the
states of R- and Sv-switches, and their respective frequency of observation in 10, 000 simulations with varying parameters for our model. The states of the R- and
Sv-switches determine whether host response persists causing immunological scarring, and whether sepsis occurs, respectively. (B–E) The dynamics of the four
phenotypes: healthy recovery (B), immunological scarring (C), sepsis (D) and sepsis accompanied with scarring (E). Solid lines and the gray shaded regions
correspond to the mean dynamics and the ± standard deviation. (F) R-switch ON time vs. Time to reach the peak of Sv for the healthy recovery case. (G) R-switch
ON time vs. Time for sepsis onset for the sepsis phenotype. (H) Boxplots representing the minimum, first quartile, median, third quartile, maximum and outlayers of
the R-switch ON time for healthy recovery and sepsis cases.
2.4. Risk Factors for Disease Phenotypes
To identify the model parameters that affect the states of the
R- and Sv-switches thereby determine the four phenotypes,
we conducted the global parameter sensitivity analysis of our
model with respect to R and Sv, respectively, using both Sobol
and eFAST sensitivity indices (Marino et al., 2008; Cannavó,
2012).
The analysis identified the three most sensitive parameters
for the propensity to turn on both the R-switch (to develop
immunological scarring) and the Sv-switch (to develop sepsis)
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(Figure 4): the rate of bacterial transmigration through the
barrier (θS), the bacterial carrying capacity (µS), and the killing
rate of bacteria by macrophages (φMS) further confirming
the importance of macrophages. Simulations with systematic
variations of these three parameters further suggest that they
affect the occurrence of sepsis and of immunological scarring, as
well as how quickly these occur after the Sp challenge (Figure 5).
These three sensitive parameters have a direct correspondence
with risk factors for disease triggered by Sp that have been
reported in the experimental literature. For example, increase
in θS can be caused by co-infection, which damages the barrier
directly or by having triggered previous immune responses
(McCullers, 2014). Increase in µS is caused by previous
infections, for example by influenza virus, that damage the
tissue, increase nutrient contents (Siegel et al., 2014), or shift the
microbiome composition affecting the dynamics of the different
bacterial populations (McCullers, 2014). φMS can be affected for
example by severe asthma (Liang et al., 2014).
Other parameters that are also affected by co-infection were
not identified to be very sensitive for the propensity to develop
sepsis (increase in Sv) or unresolved host responses (increase in
R) (Figure 4). These parameters include S+ which can increase
as a consequence of TLR2 desensitization caused by a previous
influenza virus infection (Didierlaurent et al., 2008),M that may
increase as a consequence of previous infectious events (La Gruta
et al., 2007; Yin et al., 2013), and the size of the neutrophil pool
(Nv) which may decrease by chemotherapy or severe infections
(Dick et al., 2008). The unsensitivity to the initial conditions can
be partially explained by the existence of a unique stable steady
state corresponding to the healthy recovery.
2.5. A Rapid Onset of Sepsis Triggered by a
Transient Sp Challenge
In the septic behavior observed in 15% of the simulations
(Figures 3C,D), the sepsis occurred (Sv increases above S
∗
v)
within 2 days post Sp challenge in 79% of the cases (Figure 6).
When sepsis is accompanied with immunological scarring (R
stays on and Sv increases above S
∗
v , Figure 3D), the time to sepsis
is longer than when it is not (Figure 6). The computationally
predicted rapid onset of the sepsis is consistent with experimental
observations in Andonegui et al. (2009) that the mice either
survived or died within 36 h upon Sp challenge applied directly
into the lumen of the lungs. The results suggest that rapid
treatments within 36 h are crucial to prevent the onset of sepsis.
Increasing the immune activity, for example by activation of
adaptive immune responses, could be an effective way to decrease
the risk of sepsis onset, as it elevates the switching threshold,
S∗v , which depends on the strength of the resident immune cells.
While the adaptive immunity could be activated naturally, the
time for activation of the adaptive immune responses (which
involves the de novo differentiation of naive T cells into mature
T cells) by infiltrated pathogens was experimentally evaluated to
FIGURE 4 | Global sensitivity analysis of the model with respect to (A) Sv and (B) R, using the SOBOL and eFAST sensitivity indices.
FIGURE 5 | Combinatorial effects of the three most sensitive parameters (θS, µS and φMS) on the sepsis onset time (A) and the Ron time (B). The black
circles correspond to the nominal values for (µS,φMS) and the nominal value for θS is 1.1× 10
−4. Changes in θS do not affect the Ron time.
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FIGURE 6 | Computationally predicted time for onset of sepsis.
be more than 2 days in mice (Zheng and Flavell, 1997). Such slow
activation of the adaptive immunity therefore cannot prevent the
onset of sepsis within 36 h.
These results suggest that prophylactic activation of the
adaptive immune responses, for example by vaccinations, could
be an effective strategy to prevent the incidence of sepsis, as
demonstrated by the protective effects of Sp vaccination in mice
(Cao et al., 2013). It is also consistent with the clinical suggestions
to use vaccines as a preventive measurement against transient
bacterial challenges in the high-risk patients (World Health
Organization, 2012).
2.6. Optimal Antibiotics Treatment
Regimens for Each of the Three Patient
Cohorts
Using the proposed model, we investigate optimal treatment
regimens and determine the minimal strength and duration
of antibiotics treatment that are required to prevent or revert
the pathological consequences of a transient Sp challenge. The
minimal use of antibiotics is important for tackling the problem
of antibiotics resistance (Nuorti et al., 1998), since the emergence
of antibiotic-resistant Sp strains has been associated to the
excessive use of antibiotics (Schrag et al., 2001; Prina et al.,
2015b). We consider two different types of bactricidal antibiotics
treatments in our modeling framework: apical application of
antibiotics in the luminal side of themucosa that decreases Sa and
can thereby turn off the R-switch and stop the immunological
scarring, and systemic application of antibiotics in the blood
vessel that directly decreases Sv to prevent the onset of invasive
infection (described in the Methods Section 4.3).
When the patients have immunological scarring without
sepsis (Figure 3C), the treatment by apical application of
antibiotics should aim to reduce Sa down below S
− to turn
off the R-switch (Figure 7A). Once the R-switch is turned off,
further use of antibiotics is no longer needed, as the healthy
steady state with R = Roff is locally attractive (Sa < S
+) for
all the parameter combinations tested (over 10, 000 simulations).
The minimal treatment potency of apically applied antibiotics
(minimal strength × minimal duration) to bring Sa down below
S− depends on the severity of the phenotype measured by the
deviation of the high focal point from S− (R2 = 0.46804).
When the patients are susceptible for sepsis (Figure 3D), the
treatment by systemic application of antibiotics should aim to
reduce Sv to avoid reaching S
∗
v and thereby causing invasive
infection (Figure 7B). The minimal strength of systemically
applied antibiotics allows the maximum of Sv to reach just below
S∗v , and the minimal duration of the treatment with the minimal
strength corresponds to the time required for R(t) to naturally
turn off by Sa reaching S
−. The minimal treatment potency of
systemic antibiotics to prevent sepsis depends on the severity of
the phenotype measured by the time to reach S∗v in the absence of
treatments.
When the patients are susceptible to the combination of
sepsis and immunological scarring (Figure 3E), they require
antibiotics that are strong enough to be apically applied until
Sa decreases below S
− to turn off the R-switch (Figure 7C).
Our model simulations predicted that the apical treatment is
enough to prevent invasive infection for 48% of these cases, since
the reduction of Sa also reduces Sv, but the remaining 52% of
the cases require additional application of comparatively small
amounts of antibiotics directly in the blood vessel.
The distributions of the minimal treatment strengths and
durations that we computationally predicted can be used as a
guide to design safe and effective treatment options for the three
patient cohorts. For example, our results suggest that antibiotics
treatment for 20 days can prevent or revert most of immune
scarring (Figure 7A) or invasive infection (Figure 7B), but that
a much longer antibiotics treatment is needed for patients with a
propensity for both sepsis and immune scarring (Figure 7C).
3. DISCUSSION
In this paper, we have proposed the first mathematical model
of Sp colonization of the upper airway epithelium, and
demonstrated that it robustly reproduces the healthy co-existence
between this bacterium and the host. Our mathematical model
is a hybrid system of ODEs, describing the interactions between
the bacteria, immune cells and epithelial barrier function in a
mechanistic, dynamical, quantitative and integrative way.
A key element of our model to determine the healthy and
pathological phenotypes is a “double switch motif ” (Domínguez-
Hüttinger et al., in press). The first switch describes activation
of the TLR2 signaling pathway by apically located bacteria
(Figure 1C). It can reflect both the resting, homeostatic Sp-
upper airway interactions (when R = Roff) characteristic of
Sp as a commensal bacterium, and the transient host response
to a Sp challenge (when R = Ron). Failure to inactivate
this R-switch due to impaired host-pathogen interactions, for
example by weakened immune responses (Figures 4B, 5B), can
have long term consequences such as immunological scarring
(Figure 3C) that require treatment to resolve it. The second
switch distinguishes a transient growth of Sv that can be
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FIGURE 7 | Optimal antibiotics treatment strategies for patients with (A) Immunological scarring to turn off the R-switch, (B) sepsis, and (C) sepsis and
immunological scarring. Gray shaded regions in the left column denote the minimal time of application of antibiotics in the apical side of the epithelium or in the blood
vessel (systemic application).
contained without treatments (when Sv ≤ S
∗
v) and an invasive
infection (when Sv > S
∗
v) which would require a large dose
of antibiotics treatments (Figure 1D). Our model simulations
predict that invasive infection is developed within 36 h, in
consistent with experimental observations (Andonegui et al.,
2009) that were not used for development of our model. Our
model analysis identified the most likely risk factors for an
increased susceptibility to develop invasive infection, in response
to transient Sp challenges (Figures 4, 5). Based on the state of this
double-switch motif, we characterized four different phenotypes
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(Figure 3), and identified those susceptible cohorts that require
specific antibiotics treatment to prevent or revert the adverse
effects of a Sp challenge.We further used ourmathematicalmodel
to calculate the minimal strengths and durations of antibiotics
application to effectively treat each of these disease phenotypes
(Figure 7). These results suggest that the proposed quantitative
and systems-level framework of Sp infection can be used to
design optimal and personalized treatment strategies, as it can
predict theminimal application times that are required to achieve
prevention or remission for individual patient cohort.
While our mathematical model was constructed based on
murine and in vitro experiments, future calibration of the
model with human data could make the proposed mathematical
modeling framework directly translatable to the clinic, to help
stratification of patients and identification of patient-specific
optimal treatment strategies. For example, our model analysis
suggested that the efficacy of bacterial killing by immune cells
(Figures 4, 5) could be used as a marker to distinguish vulnerable
patient cohorts who would require preventive treatments before
the onset of sepsis. This efficacy could be determined ex vivo,
from serum or broncheoalveolar lavage fluid extracted from
patients, to predict patient-specific responses characteristic of
those vulnerable patient cohorts. A similar approach to stratify
patients based on measurements of isolated components of
a more complex physiological system has been shown to be
effective for other complex diseases (Fey et al., 2015). The
computational method demonstrated in this paper could then
allows us to predict the minimal strength and duration of
antibiotics application for individual patient cohort and for
a specific antibiotics, given the experimentally determined
information on the efficacy of the antibiotics (Mandell et al., 2007;
Prina et al., 2015b) and the growth rate of the pneumococcal
strain in the patients’ serum. Our model will also enable us to
investigate and design preventive strategies by early vaccines
against invasive infection in patient cohorts who are identified
to be high-risk. Extension of our modeling framework to human
disease will also require systematic investigation of the dose-
dependent outcome of Sp-airway interactions (Yershov et al.,
2005). Another interesting future research direction includes the
assessment of the long-term effects of immunological scarring
on subsequent Sp challenges with different amplitudes and
frequencies to identify the mechanisms behind the increased
risk of developing serious infections after a first bacterial
challenge (Habibzay et al., 2013). Finally, extending our model
to incorporate the local spread of Sp from the upper airway
epithelium to the lung and other sites on the respiratory
epithelium that are normally sterile, for example by combining
our model to the model of Smith et al. (2013), could allow us to
investigate the association between a dysregulated colonization
of the upper airway epithelium and the development of
pneumococcal pneumionia.
The results of our mathematical model of commensal bacteria
infection at the upper airway epithelium shed light on the
mechanism behind a loss of homeostasis caused by dysregulation
of the complex interactions between epithelial surfaces and
microorganisms. A key element in this control structure is
a “double-switch motif,” which has been shown to govern
other complex epithelial diseases, such as Atopic dermatitis
(Domínguez-Hüttinger et al., in press) and cancer (Tian
et al., 2013). Analysis of complex disease with a mechanistic,
quantitative and systems-level framework as proposed here will
help to reveal further general mechanisms underlying epithelium
function in health and disease.
4. METHODS
4.1. Model Description
The proposed model for commensal bacterial infection describes
the dynamics of bacterial load on the surface of the airway
epithelium barrier, Sa(t)[CFU/ml], infiltrated bacterial load,
Sv(t)[CFU/ml], concentrations of neutrophils and macrophages
on the surface of the mucosal barrier, N(t) and M(t) [cells/ml],
and the strength of barrier integrity, B(t) relative to themaximum
strength, by
dSa(t)
dt
=
κS
µS
Sa(t)(1− Sa(t))−
θS
1+ ǫSBB(t)
Sa(t)
− φNSN(t)Sa(t)− φMSM(t)Sa(t), (1a)
dSv(t)
dt
= κSSv(t)+
θS
1+ ǫSBB(t)
Sa(t)−
δS
K + Sv(t)
Sv(t), (1b)
dN(t)
dt
= α
R(Sa(t))
(1+ ǫNBB(t))(1+ ǫNMM(t))
Nv − δNN(t), (1c)
dM(t)
dt
= β
N(t)
1+ ǫMBB(t)
Mv − δMM(t), (1d)
dB(t)
dt
=
κB
1+ ǫBSR(Sa(t))
B(t)(B˜− B(t))
− φSBR(Sa(t))B(t)− φNBN(t)B(t). (1e)
The variable R(Sa(t)) denotes the Sa-dependent TLR activation
level described by a perfect switch,
R(Sa(t)) =


Roff if Sa(t) < S
− or {S−≤ Sa(t) < S
+ and
R(Sa(t
−)) = Roff},
Ron if Sa(t) ≥ S
+ or {S−≤ Sa(t) < S
+ and
R(Sa(t
−)) = Ron},
(2)
where t− is a time slightly before the time t. The dynamics of
the TLR activity stabilizes within hours (Filewod et al., 2009; Witt
et al., 2009; Hoffman et al., 2015).
The growth of the bacterial load on the apical side of the
barrier, Sa, is modeled by a logistic equation (Smith et al., 2011),
where the growth rate is limited by a carrying capacity (saturation
term µS) that reflects the limited availability of nutrients in the
epithelial lumen (Burnaugh et al., 2008). Sa is eradicated by
immune cells,N andM, and transmigrates to the basal side of the
epithelial barrier. The transmigrated bacteria, Sv, is assumed to
grow exponentially in the blood vessel with abundant nutrients,
but is killed by resident immune cells. The capacity to contain
Sv is described by the saturated degradation of Sv, leading to
the complete decay of Sv if it is below the threshold S
∗
v , which
corresponds to the unstable steady state of the ODE for Sv when
Sa = S
−.
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Recruitment of neutrophils (N) and macrophages (M) to the
site of infection from their respective pool in the blood vessel (Nv)
and the airway tissues (Mv) is inhibited by the epithelium barrier
integrity (B), and is enhanced by the TLR activation (R) and the
recruited neutrophils, respectively. Recruitment of N is further
inhibited byM. N andM decay with a respective constant decay
rate, as de novo production of the immune cells does not occur
outside the bone marrow (Tak et al., 2013) and they do not divide
in the epithelial tissue.
The self-recovery of the mucosal barrier to its homeostatic
level (Nusrat et al., 1997; Coyne et al., 2002; Heijink et al., 2012) is
modeled in a phenomenological manner, with the recovery rate
being compromised by a decreased gene expression of epithelial
cell differentiation markers (Clarke et al., 2011) induced by TLR
activation. The barrier is directly damaged by transmigrating
neutrophils and by proteases that are activated via TLR signaling
(Chun and Prince, 2009). The switch-like activation of the
TLR signaling is triggered by apically located bacteria, and is
modeled by a phenomenological representation (Mochan et al.,
2014; Domínguez-Hüttinger et al., in press). For simplicity, the
inhibition by x is modeled phenomenologically by 11 + x .
4.2. Numerical Integration of the Hybrid
Model
All the numerical model analysis was conducted using MATLAB
version R2014a (The MathWorks, Inc., Natick, MA, USA).
Numerical integration was conducted by ode15s from the
initial conditions corresponding to a transient Sp challenges with
Sa(0) = 10
7 CFU/ml, Sv(0) = 0 CFU/ml, N(0) = 0 cells/ml,
M(0) = 10 cells/ml, and B(0) = 1, with R(0) = 1, as in
the experiments in Zhang et al. (2009). The switch-dependent
governing equation was chosen by the event-location
function.
4.3. Modeling Antibiotics—Calculation of
Minimal Strength and Minimal Duration of
Antibiotics Treatment
Wemodel the effects of bactericidal antibiotics, such as penicillin,
ceftriaxone and amoxilin, which are commonly prescribed to
treat pneumococcal infection (Mandell et al., 2007; Prina et al.,
2015b) by dSv
dt
= −VSv(t) (systemic application of antibiotics)
and dSa
dt
= −ASa(t) (apical application of antibiotics), where V
and A represent a constant strength of antibiotics that kill Sv(t)
and Sa(t), respectively. The strength of the antibiotics (with a unit
of 1/h) is described by V = EVDV or A = EADA, where EV and
EA is the antibiotics killing efficacy andDV andDA is the amount
applied, and can be chosen in the clinic by either selecting an
antibiotic with a particular killing efficacy and/or adjusting the
dose administrated. The killing efficacy of an antibiotic over a
specific bacterial strain is commonly evaluated by the Minimal
Inhibitory Concentration (MIC), the lowest concentration of
antibiotics that will inhibit the visible growth of a bacterium
after overnight incubation in a kinetic growth assay. From such
experimental information, the antibiotics efficacy in our model,
EA (and EV) can be calculated as EA =
κS
µS
(1 − SMIC(t)) ×
1
DMICA
,
where SMIC(t) is the concentration of Sp exposed to an antibiotics
dose of DMICA = MIC, and hence does not increase further. This
expression is obtained from the steady state equation dSMIC(t)
dt
=
κSµS(1 − SMIC(t)) − EAD
MIC
A SMIC(t) = 0, which holds for the
value of SMIC(1day) = Sa in these experiments.
Minimal strength of antibiotics treatment to achieve
remission was determined by checking whether Sv(t) < S
∗
v
or Sa(t) < S
− is achieved while gradually increasing V or A,
respectively, by an increment of 0.01. The minimal duration of
treatments corresponds to the time required to achieve Sa = S
−.
The minimal antibiotics treatment regimens to revert immune
scarring without invasive infection (Figure 7A) were calculated
under the assumptions that the treatment starts when Sa reached
its steady state, after a transient Sa challenge that was modeled
with initial conditions of Sa(0) = 10
7 CFU/ml, Sv(0) = 0
CFU/ml, N(0) = 0 cells/ml, M(0) = 10 cells/ml, and B(0) = 1,
with R(0) = 1. For the regimens to prevent invasive infection
(Figure 7B), as well as to reverse immunological scarring and to
prevent sepsis (Figure 7C), we assumed that the treatment starts
at the time of the Sa challenge.
4.4. Robustness Analysis and Parameter
Sensitivity Analysis
We varied all the model parameters over one order of magnitude
(0.1 - 10 times) around the nominal values, and the initial
conditions N(0),M(0) and B(0) within the intervals [0 1,000], [0
100] and [0 1], respectively. Robustness of the healthy behavior
was tested by simultaneously varying all the parameters which
were sampled from uniform distributions for 10, 000 iterations.
The global parameter sensitivity was evaluated by 10, 000
iterations using the Global Sensitivity Analysis Toolbox for
Matlab (Cannavó, 2012), with respect to the final concentrations
of Sv and R at 7 days post Sp challenge with Sa(0) = 10
7 CFU/ml.
4.5. Focal Point Analysis
We conducted a focal point analysis to determine the long-term
behavior of the model in absence of a Sp challenge. Following
the methodology in Oyarzún et al. (2012), we considered two
subsystems for Equation (1), defined by fixingR to eitherR = Roff
or to R = Ron, and evaluated the local stability of their steady
states.
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